Loading…
H.R. 8018119th CongressIn committeeLatest action Mar 19, 2026Decoded by AI · checked against the record
The plain-language version leads. The official text is always the reference.
The ISLET Act would regulate donor pancreatic islets like transplant organs instead of drugs or biological products.
35-second read · 4 questions answered below
The ISLET Act would classify human islets from deceased donors the same way whole organs like kidneys are classified, rather than as drugs, biological products, or human tissue products. HHS would have one year to update related regulations and must report to Congress on progress within six months.
This affects patients needing islet transplants (often people with severe type 1 diabetes), transplant doctors and hospitals, organ procurement organizations, and companies that process islets.
The reclassification would shift islets out of drug/biological product regulatory pathways into organ transplant rules, changing which approval processes apply to their use.
AI-drafted summary. Verify it against the official text before you act on it. Read the official bill on Congress.gov
Right now: a House committee is reviewing it. If the Senate changes it, it goes back to the House before reaching the President.
Latest action: — Referred to the House Committee on Energy and Commerce.